Simultaneous extraction of hepatitis C virus (HVC), hepatitis B virus, and HIV-1 from plasma and detection of HVC RNA by a reverse transcriptase- polymerase chain reaction assay designed for screening pooled units of donated blood

Transfusion

Volumn 39, Issue 10, 1999, Pages 1111-1119

  Sun, R ^a   Schilling, W ^a   Jayakar, H ^a   Ku, J ^a   Wang, J ^a   Rosenstraus, Maurice ^a   Spadoro, J ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIRUS DETECTION; VIRUS INFECTION;

BLOOD; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; FLAVIVIRIDAE; GENOTYPE; HEPACIVIRUS; HIV-1; HUMANS; MASS SCREENING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0032826718     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39101111.x     Document Type: Article

References (20)

1. Dodd RY. Adverse consequences of blood transfusion: quantitative risk estimates. In: Nance ST, ed. Blood supply: risks, perceptions and prospects for the future. Bethesda: American Association of Blood Banks, 1994:1-24.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
3. Holland PV. Viral infections and the blood supply (editorial). N Engl J Med 1996;334:1734-5.
4. Kleinman SH, Busch MP. General overview of transfusion transmitted infections. In: Petz LD, Swisher S, Kleinman SH, et al., eds. Clinical practice of transfusion medicine, 3rd ed. New York: Churchill Livingstone, 1996:809-21.
5. Busch MP, Stramer SL, Kleinman SH. Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives. In: Garratty G, ed. Applications of molecular biology to blood transfusion medicine. Bethesda: American Association of Blood Banks, 1997:123-76.
6. Soriano V, Dronda F, Gonzalez-Lopez A, et al. HIV-1 causing AIDS and death in a seronegative individual (letter). Vox Sang 1994;67:410-1.
7. Persistent lack of detectable HIV-1 antibody in a person with HIV infection - Utah, 1995. MMWR Morb Mortal Wkly Rep 1996;45:181-5.
8. Garcia Z, Taylor L, Ruano A, et al. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. J Med Virol 1996;49:218-22.
9. Mortimer J. Intersecting pools and their potential application in testing donated blood for viral genomes. Vox Sang 1997;73:93-6.
10. Rosenstraus M, Gutekunst K, Herman S, et al. Improved COBAS AMPLICOR viral assays as a basis for mini-pool screening of viruses in blood or plasma. Infusionsther Tranfusionsmed 1998;25:153-9.
11. Rosenstraus M, Wang Z, Chang SY, et al. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol 1998;36:191-7.
12. Young KK, Resnick R, Myers T. Detection of hepatitis C virus RNA by a combined reverse transcriptase-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
13. Sun R, Ku J, Jayakar H, et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998;36:2964-9.
14. Schockmel GA, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:179-83.
15. Evaluation of precision performance of clinical chemistry devices. 2nd ed. Tentative guideline. NCCLS document EP5-T2. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
16. Alter HJ, Sanchez-Pescador R, Urdea MS, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2:121-32.
17. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
18. Ichijo T, Matsumoto A, Kobayashi M, et al. Quantitative measurement of HCV RNA in the serum: a comparison of three assays based on different principles. J Gastroenterol Hepatol 1997;12:500-6; erratum appears J Gastroenterol Hepatol 1998;13:F550.
19. Shiratori Y, Kato N, Yokosuka O, et al. Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon. J Hepatol 1997;27:437-44.
20. Schmidt WN, Wu P, Han JQ, et al. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J Infect Dis 1997;176:20-6.